Servier Expands Neurology Pipeline with Acquisition of KER-0193 for Fragile X Syndrome Servier's recent acquisition of KER-0193 aims to treat Fragile X syndrome, enhancing their neurology pipeline and addressing unmet medical needs in autism spectrum disorder.

Servier Expands Neurology Pipeline with Acquisition of KER-0193 for Fragile X Syndrome #France #Servier #Suresnes #KER-0193 #Fragile_X

Spinogenix Receives FDA Approval for SPG601 in Fragile X Syndrome Treatment Spinogenix has achieved a significant milestone with the FDA's support for SPG601, a pioneering treatment for Fragile X syndrome, addressing crucial needs in patient care.

Spinogenix Receives FDA Approval for SPG601 in Fragile X Syndrome Treatment #USA #Los_Angeles #Spinogenix #SPG601 #Fragile_X

Spinogenix's SPG601 Receives Orphan Drug Designation for Fragile X Syndrome Treatment Spinogenix's SPG601 has been granted orphan drug designation by the EMA for treating Fragile X Syndrome, marking a significant step in therapies for this condition.

Spinogenix's SPG601 Receives Orphan Drug Designation for Fragile X Syndrome Treatment #USA #Los_Angeles #Spinogenix #SPG601 #Fragile_X